Scilex Holding Company（股票代码：SCLX）宣布，其旗下两家子公司——Acea Therapeutics, Inc.与Acea Pharma, Inc.——已与Phoenix Asia Holdings Limited（股票代码：PHOE）正式签署了一项具有约束力的最终协议。
此项协议的达成标志着双方合作关系的正式确立，为未来在相关领域的业务拓展奠定了基础。协议的具体条款和合作细节尚未对外公开披露。
此次交易预计将促进Scilex Holding Company在相关市场的战略布局，并可能对其未来的业务发展和财务状况产生积极影响。市场将密切关注后续进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.